Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.767
+0.032 (4.41%)
At close: Jan 17, 2025, 4:00 PM
0.770
+0.002 (0.29%)
Pre-market: Jan 21, 2025, 8:28 AM EST
Seres Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$5.63
Upside
+633.65%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,203.10% | Nov 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $1.25 | Strong Buy | Maintains | $1.25 | +62.89% | Nov 13, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Oct 24, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,203.10% | Sep 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,203.10% | Aug 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $1.25 | Strong Buy | Maintains | $1.25 | +62.89% | Aug 14, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +1,203.10% | Jun 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +421.24% | May 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +681.86% | May 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +551.55% | Mar 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +942.48% | Mar 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +1,072.79% | Jan 16, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4 → $1.25 | Strong Sell | Maintains | $4 → $1.25 | +62.89% | Nov 3, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $12 | Buy | Initiates | $12 | +1,463.72% | Jun 26, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +1,203.10% | Apr 28, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.